Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism.
Open Access
- 1 July 1985
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 260 (15) , 9057-9067
- https://doi.org/10.1016/s0021-9258(17)39456-5
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Oxidation of sparteines by cytochrome P-450: evidence against the formation of N-oxidesJournal of Medicinal Chemistry, 1984
- Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylationFEBS Letters, 1984
- Purification and characterization of six cytochrome P-450 isozymes from human liver microsomesBiochemistry, 1983
- Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresisBiochemistry, 1982
- Defective Oxidation of DrugsClinical Pharmacokinetics, 1982
- Immunological comparison of rat, rabbit, and human liver NADPH-cytochrome P-450 reductasesBiochemistry, 1981
- Ethnic difference in drug metabolism: debrisoquine 4-hydroxylation in Caucasians and OrientalsCanadian Journal of Physiology and Pharmacology, 1980
- The polymorphic 4-hydroxylation of debrisoquine in a Saudi arab populationXenobiotica, 1980
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Assessment of Compositional Relatedness between ProteinsNature, 1968